Latest stories on CRDL
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference
PR Newswire56 · neutralgeneral
Peer-Reviewed Phase II Results in JAHA Highlight CardiolRx’s Potential as MAVERIC Study Nears Completion
July 14, 2026
MarketChameleon73 · bullishproduct/pr
Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association
PR Newswire67 · bullishproduct/pr
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit
TipRanks56 · neutralproduct/pr
Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit
PR Newswire56 · neutralgeneral
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders
PR Newswire50 · neutralgeneral
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
PR Newswire73 · bullishproduct/pr